Improving Survival in Endometrial Cancer with Node Metastases
Author Information
Author(s): T Onda, H Yoshikawa, K Mizutani, M Mishima, H Yokota, H Nagano, Y Ozaki, A Murakami, K Ueda, Y Taketani
Primary Institution: University of Tokyo
Hypothesis
Does systematic aortic and pelvic lymphadenectomy followed by adjuvant therapy improve survival in node-positive endometrial cancer patients?
Conclusion
Aortic and pelvic lymphadenectomy followed by chemotherapy and radiation therapy based on node status improves survival in endometrial cancer patients with positive nodes.
Supporting Evidence
- Five-year survival was 95% for patients with negative nodes and 84% for those with positive nodes.
- Patients with pelvic node metastases alone had a 100% five-year survival rate.
- Patients with aortic node metastases had a 75% five-year survival rate.
Takeaway
Doctors found that removing lymph nodes and giving treatment helps women with a certain type of cancer live longer.
Methodology
Patients underwent systematic aortic and pelvic lymphadenectomy followed by chemotherapy and radiation therapy based on node status.
Limitations
The study may not represent all endometrial cancer patients as it focused on those with node-positive disease.
Participant Demographics
Mean age of participants was 55.8 years, with a range from 30 to 77 years.
Statistical Information
P-Value
0.30
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website